ABOUT US

Experience:

Post-Doc, Max-Planck Institute of Biochemistry

Project Leader of DFG, Max-Planck Institute of Biochemistry

Principal lnvestigator, Tianjin lnstitute of lndustrial Biotechnology, Chinese Academy of Sciences

Leading Science & Technology Entrepreneur Talents Nanjing 321

Leading Entrepreneur Talents Suzhou Industrial Park

Education:

Nankai University, BS Biochemistry/MS Molecular biology

Georg-August-Universität/Max-Planck lnstitute of Biophysical Chemistry, Goettingen, Germany, Ph.D Neurobiology

Responsibilities:

Establishing a world-class R&D structure specializing in bioconjugates, integrating innovative science and cutting-edge technologies.

Leading the development of next generation first/best-in-class bioconjugate drug pipelines that significantly advance the current treatment landscape.

Leading technology innovation at GQ, focusing on unique iLDC/iGDC conjugation technologies, stable linker technologies, and novel payload development.

Experience:

Chief Scientific Officer (CSO) at Curon Biopharmaceutical, China

Vice President (VP) at Samsung Bioepis, Korea

Principal Research Scientist at Eli Lilly Research Laboratories, USA

Post-Doctoral Researcher at Tularik Inc. (Amgen SF), USA

Education:

Ph.D. in Biology from Purdue University, USA

Responsibilities:

Make the GQ’s clinical development strategy

Direct and oversee the design and implementation of all stage clinical projects

Prepare and direct overall clinical development plans

Design scientifically rigorous clinical development programs for the various indications

Monitor study progress, leading the analyses and data evaluation process for progress reporting and presentations to internal senior management team and external advisory and other relative groups

Prepare briefing and regulatory documents for regulatory agencies, such as BLAs, INDs, DSUR, and communicate with regulatory agencies about medical and other related issues

Planning and promotion of clinical professional activities

Experience:

Associate Chief Physician, Ruijin Hospital, Shanghai Jiaotong University School

Associate Chief Physician, associate professor, Chinese PLA General Hospital & Chinese PLA Medical School

Education:

Post-doctor, Dana-Farber Cancer Institute, USA

Ph.D., MD. in oncology, Chinese PLA General Hospital & Chinese PLA Medical School, China

M.S., in pathology and pathophysiology, Chinese PLA General Hospital & Chinese PLA Medical School, China

B.S., in Clinical medicine, Southern Medical University (The First Military Medical University of the PLA), China

Responsibilities:

Licensing and cooperation of intelligent continuous conjugation platform technology

Licensing and cooperation of innovative product pipeline

Experience:

Chief Business Development Officer, SciClone Pharmaceuticals

Chief Business Officer, ChiaTai TianQing Pharmaceutical Group

Chief Business Officer, Livzon Bio

Board Member, Chief Business Officer, Xcovery Holdings/Betta Pharmaceuticals

Senior Director, Transaction and Strategy, Johnson& Johnson Innovation

Vice President of Strategic Collaboration, Betta Pharmaceuticals

Head of Licensing & Development, Esperion Division of Pfizer, Pfizer

Senior Manager, Business Development, Esperion Therapeutics

Education:

Ph.D., Biochemistry, Ohio State University

M.S., Business Administration, University of Michigan Ross School of Business

B.S., Biochemistry, Peking University

Responsibilities:

Establish and optimize GMP quality system

Responsible for CMC development and manufacturing to ensure the smooth progress of the projects

Experience:

Chief Technology Officer, Harbour BioMed, Suzhou/Shanghai, PR China

Senior Vice President, Innovent Biologics, Suzhou, PR China

Vice President, WuXi Biologics, Shanghai , PR China

Vice President, Sinocell Tech, Beijing, PR China

Education:

Ph.D., Bioanalytical Chemistry, Indiana University, Bloomington